Publikationen von Marcelo Páez-Pereda

Stalla, G. K.; Dimopoulou, C.; Jung-Sievers, C.; Arzt, E.; Páez-Pereda, M.; Theodoropoulou, M.; Ciato, D.; Renner, U.: Translational research in pituitary tumours. EUROPEAN JOURNAL OF ENDOCRINOLOGY 182 (1), S. R1 - R13 (2020)

Ciato, D.; Li, R.; Monteserin Garcia, J. L.; Papst, L.; D'Annunzio, S.; Hristov, M.; Tichomirowa, M. A.; Belaya, Z.; Rozhinskaya, L.; Buchfelder, M. et al.; Theodoropoulou, M.; Paez-Pereda, M.; Stalla, G. K.: Inhibition of Heat Shock Factor 1 Enhances Repressive Molecular Mechanisms on the POMC Promoter. NEUROENDOCRINOLOGY 109 (4), S. 362 - 373 (2019)

Oyola, M. G.; Shupe, E. A.; Soltis, A. R.; Sukumar, G.; Paez-Pereda, M.; Larco, D. O.; Wilkerson, M. D.; Rothwell, S.; Dalgard, C. L.; Wu, T. J.: Sleep Deprivation Alters the Pituitary Stress Transcriptome in Male and Female Mice. FRONTIERS IN ENDOCRINOLOGY 10, 676 (2019)

Balsevich, G.; Häusl, A. S.; Meyer, C. W.; Karamihalev, S.; Feng, X.; Pöhlmann, M.; Dournes, C.; Uribe-Marino, A.; Santarelli, S.; Labermaier, C. et al.; Hafner, K.; Mao, T.; Breitsamer, M.; Theodoropoulou, M.; Namendorf, C.; Uhr, M.; Páez-Pereda, M.; Winter, G.; Hausch, F.; Chen, A.; Tschoep, M. H.; Rein, T.; Gassen, N. C.; Schmidt, M. V.: Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function. NATURE COMMUNICATIONS 8, 1725 (2017)

Ciato, D.; Mumbach, A. G.; Páez-Pereda, M.; Stalla, G. K.: Currently used and investigational drugs for Cushing's disease. EXPERT OPINION ON INVESTIGATIONAL DRUGS 26 (1), S. 75 - 84 (2017)

Aprile-Garcia, F.; Metzger, M. W.; Páez-Pereda, M.; Stadler, H.; Acuna, M.; Liberman, A. C.; Senin, S. A.; Gerez, J.; Hoijman, E.; Refojo, D. et al.; Mitkovski, M.; Panhuysen, M.; Stuehmer, W.; Holsboer, F.; Deussing, J. M.; Arzt, E.: Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function. PLOS ONE 11 (3), e0151862 (2016)

Kabra, D. G.; Pfuhlmann, K.; Garcia-Caceres, C.; Schriever, S. C.; Garcia, V. C.; Kebede, A. F.; Fuente-Martin, E.; Trivedi, C.; Heppner, K.; Uhlenhaut, N. H. et al.; Legutko, B.; Kabra, U. D.; Gao, Y.; Yi, C.-X.; Quarta, C.; Clemmensen, C.; Finan, B.; Mueller, T. D.; Meyer, C. W.; Páez-Pereda, M.; Stemmer, K.; Woods, S. C.; Perez-Tilve, D.; Schneider, R.; Olson, E. N.; Tschoep, M. H.; Pfluger, P. T.: Hypothalamic leptin action is mediated by histone deacetylase 5. NATURE COMMUNICATIONS 7, 10782 (2016)

Páez-Pereda, M.; Arzt, E.: Function and Structure of the RWD Domain. JOURNAL OF BIOLOGICAL CHEMISTRY 290 (33), S. 20627 - 20627 (2015)

Riebold, M.; Kozany, C.; Freiburger, L.; Sattler, M.; Buchfelder, M.; Hausch, F.; Stalla, G. K.; Páez-Pereda, M.: A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease. NATURE MEDICINE 21 (3), S. 276 - 280 (2015)

Druker, J.; Liberman, A. C.; Antunica-Noguerol, M.; Gerez, J.; Paez-Pereda, M.; Rein, T.; Iniguez-Lluhi, J. A.; Holsboer, F.; Arzt, E.: RSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity. MOLECULAR AND CELLULAR BIOLOGY 33 (11), S. 2116 - 2127 (2013)

Monteserin-Garcia, J.; Al-Massadi, O.; Seoane, L. M.; Alvarez, C. V.; Shan, B.; Stalla, J.; Paez-Pereda, M.; Casanueva, F. F.; Stalla, G. K.; Theodoropoulou, M.: Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis. FASEB JOURNAL 27 (4), S. 1561 - 1571 (2013)

Schmidt, M. V.; Paez-Pereda, M.; Holsboer, F.; Hausch, F.: The Prospect of FKBP51 as a Drug Target. ChemMedChem 7 (8), S. 1351 - 1359 (2012)

Paez-Pereda, M.; Hausch, F.; Holsboer, F.: Corticotropin releasing factor receptor antagonists for major depressive disorder. Expert Opinion on Investigational Drugs 20 (4), S. 519 - 535 (2011)

Labeur, M.; Paez-Pereda, M.; Haedo, M.; Arzt, E.; Stalla, G. K.: Pituitary tumors: Cell type-specific roles for BMP-4. Molecular and Cellular Endocrinology 326 (1-2), S. 85 - 88 (2010)

Cerovac, V.; Monteserin-Garcia, J.; Rubinfeld, H.; Buchfelder, M.; Losa, M.; Florio, T.; Paez-Pereda, M.; Stalla, G. K.; Theodoropoulou, M.: The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells. Cancer Research 70 (2), S. 666 - 674 (2010)

Correa-de-Santana, E.; Fröhlich, B.; Labeur, M.; Paez-Pereda, M.; Theodoropoulou, M.; Monteserin, J. L.; Renner, U.; Stalla, G. K.: NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Experimental and Clinical Endocrinology & Diabetes 117 (10), S. 656 - 656 (2009)

Fröhlich, B.; Correa-de-Santana, E.; Theodoropoulou, M.; Labeur, M.; Paez-Pereda, M.; Renner, U.; Stalla, G. K.: Activation of NOD and TLR4 innate immune receptors in tumoral pituitary cells and their effects on downstream targets. Experimental and Clinical Endocrinology & Diabetes 117 (10), S. 656 - 656 (2009)

Correa-de-Santana, E.; Fröhlich, B.; Labeur, M.; Paez-Pereda, M.; Theodoropoulou, M.; Monteserin, J. L.; Renner, U.; Stalla, G. K.: NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Journal of Endocrinology 203 (1), S. 111 - 122 (2009)

Giacomini, D.; Paez-Pereda, M.; Stalla, J.; Stalla, G. K.; Arzt, E.: Molecular Interaction of BMP-4, TGF-beta, and Estrogens in Lactotrophs: Impact on the PRL Promoter. Molecular Endocrinology 23 (7), S. 1102 - 1114 (2009)

Labeur, M.; Paez-Pereda, M.; Arzt, E.; Stalla, G. K.: Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas. Reviews in Endocrine & Metabolic Disorders 10 (2 Sp. Iss. SI), S. 103 - 109 (2009)